Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Adenocarcinoma Locally Advanced × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3 Pancreatic Neoplasms 2 Pancreatic Adenocarcinoma Locally Advanced 1 Lymphatic Metastasis 1 Locally Advanced Pancreatic Cancer 1 Gynecological Cancers 1 Colorectal Neoplasms 1

Interventions

Electroporation 1 Cryosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07306273 2025-12-29

IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Ruijin Hospital

Phase 2 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma Locally Advanced

Data powered by HemOnc (CC BY 4.0) Colophon ⚡